{"disease":{"id":"hemoglobinuria-paroxysmal","name":"hemoglobinuria paroxysmal"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06903234","title":"Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH Registry","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT00566696","title":"Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":true},{"nct_id":"NCT04463056","title":"Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"AO GENERIUM","has_results":false},{"nct_id":"NCT00867932","title":"Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}